
Early Detection of Lung Cancer Through RGCC Technology
Lung cancer remains one of the most common cancers worldwide, with a high mortality rate. One of the primary challenges in lung cancer management is its late diagnosis, as early-stage lung cancer often presents with no obvious symptoms. As a result, many patients are diagnosed at an advanced stage, limiting their treatment options and reducing survival rates. While conventional screening methods such as chest X-rays and CT scans can detect certain abnormalities, they often lack the sensitivity to identify lung cancer in its earliest stages. This makes the search for more precise early detection methods essential for improving patient outcomes.